Mileutis Revenue and Competitors
Estimated Revenue & Valuation
- Mileutis's estimated annual revenue is currently $7.1M per year.
- Mileutis's estimated revenue per employee is $155,000
Employee Data
- Mileutis has 46 Employees.
- Mileutis grew their employee count by 5% last year.
Mileutis's People
| Name | Title | Email/Phone |
|---|
Mileutis Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Mileutis?
Mileutis is a bio-pharmaceutical company focused on the discovery, development, and commercialization of novel and biologically sourced, safe and residual-free therapies for animal and human health. Our lead products, Imilacâ„¢ and Milacâ„¢, target the main concern in the dairy industry: the management, treatment, and prevention of mastitis in dairy cows. Mileutis' technology and products consist of milk-derived peptides and specific protein fragments that have a positive impact on conditions that influence health and reduce antibiotic use in animal health management. Our novel therapies offer for the first time ever a non-residual, non-antibiotic solution for the biggest health issue of the dairy market. Our leading product line will not only replace antibiotics in the dairy farm but will improve cow wellbeing and provide additional and significant economic value to farmers by increasing milk yield and productivity.
keywords:N/A
N/A
Total Funding
46
Number of Employees
$7.1M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Mileutis News
Mileutis is making significant strides towards combating anti-microbial resistance (AMR), often caused and exacerbated by the overuse of...
Other Companies in Ness Ziona
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $12.7M | 63 | -2% | N/A |
#2 | $9.5M | 71 | 3% | $25.2M |
#3 | $11.2M | 73 | 12% | N/A |
#4 | $19.1M | 78 | 5% | N/A |
#5 | $25.7M | 78 | -7% | N/A |